FDA
-
-
-
-
-
-
-
NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x
-
-
-
-
-
-
-
NeOnc posts wider Q2 loss, plans NEO100 trial data release Aug. 12
-
-
-
-
-
-
-
Three Biotechs Deliver Catalysts to Watch
-
-
-
-
-
-
-
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
-
-
-
-
-
-
-
Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND
-
-
-
-
-
-
-
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
-
-
-
-
-
-
-
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America
-
328,641 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

